Eli Lilly & Co.
(NYSE : LLY)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
BMYBristol-Myers Squibb Co.
-0.27%63.771.4%$1739.02m
JNJJohnson & Johnson
0.07%141.440.7%$876.14m
PFEPfizer Inc.
-0.55%38.330.9%$729.42m
MRKMerck & Co., Inc.
0.32%89.240.7%$685.29m
ABBVAbbVie, Inc.
-1.07%87.782.3%$607.65m
LLYEli Lilly & Co.
-0.14%121.531.1%$364.17m
NVSNovartis AG
0.25%93.290.2%$151.08m
AZNAstraZeneca Plc
0.92%48.361.2%$138.40m
GSKGlaxoSmithKline Plc
0.13%45.990.2%$137.93m
SNYSanofi
0.57%49.790.2%$114.51m
RETAReata Pharmaceuticals, Inc.
2.84%206.753.5%$108.66m
KRTXKaruna Therapeutics, Inc.
-11.24%65.250.0%$105.65m
NVONovo Nordisk A/S
1.33%57.250.1%$92.18m
ALLKAllakos, Inc.
-2.21%123.190.0%$74.02m
FTSVForty Seven, Inc.
-7.72%35.750.0%$50.91m

Company Profile

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. It operates through the following segments: Human Pharmaceutical Products and Animal Health Products. The Human Pharmaceutical products segment includes the discovery, development, manufacturing, marketing and sales of human pharmaceutical products worldwide in the following therapeutic areas: neuroscience, endocrinology, oncology, cardiovascular and other. The Animal health Products segment operating through the Elanco Animal Health division, develops, manufactures, and markets products for both food and companion animals. The Animal health products include Rumensin, Tylan, Posilac, Paylean and other products for livestock and poultry, as well as Trifexis, Comfortis, and other products for companion animals. The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.